Hallazgos ecocardiográficos posteriores a infección por SARS-CoV-2 en residentes cardiopulmonarmente asintomáticos / Echocardiographic findings after SARS-CoV-2 infection in residents cardiopulmonarily asymptomatic
DOI:
https://doi.org/10.5281/zenodo.13306709Palabras clave:
COVID-19, SARS-CoV-2, Insuficiencia de la Válvula Tricúspide, Disfunción Ventricular / COVID-19, Tricuspid Valve Insufficiency, Ventricular DysfunctionResumen
Resumen
Introducción: la enfermedad por SARS-CoV-2 presenta un amplio espectro de complicaciones y repercusiones cardiovasculares, renales y cognitivas. Los principales hallazgos cardiovasculares son pericarditis, miocarditis y trastornos del ritmo, descritos en un 5 a 11% de la población general. Sin embargo, en México no existe información concreta sobre las repercusiones cardiovasculares de la infección en personal sanitario.
Objetivo: identificar los hallazgos ecocardiográficos post-infección por SARS-CoV-2 en médicos residentes de un hospital de concentración de tercer nivel.
Métodos: Se realizó un estudio descriptivo. Se seleccionaron 62 médicos residentes con diagnóstico de COVID-19 en un periodo de marzo 2020 a febrero 2023. Se les realizaron ecocardiogramas transtorácicos y posteriormente se describieron los hallazgos obtenidos.
Resultados: se reclutaron 62 residentes, 38 hombres y 24 mujeres. Los principales hallazgos ecocardiográficos fueron: refringencia del pericardio (90.3%), derrame pericárdico (6.5%), movilidad del ventrículo izquierdo anormal (1.6%), función diastólica anormal (8.1%), insuficiencia aórtica (6.5%), insuficiencia mitral (19.4%), insuficiencia pulmonar (35.5%), tricúspidea (80.6%), FEVI media de 65% y PSAP de 23 mmHg.
Conclusiones: los hallazgos ecocardiográficos más relevantes fueron pericardio refringente, derrame pericárdico, disfunción diastólica del ventrículo izquierdo e insuficiencia valvular, predominio en hombres.
Abstract
Background: SARS-CoV-2 disease is associated with a wide spectrum of cardiovascular, renal, and cognitive complications and effects. The most common cardiovascular findings are pericarditis, myocarditis and arrhythmias described in 5-11% of the general population. Specific information on cardiovascular outcomes in healthcare workers in Mexico is lacking.
Objective: To determine the echocardiographic findings after SARS-CoV-2 infection in residents at a tertiary care teaching hospital.
Material and methods: A prospective, cross-sectional, and selective study was performed. A sample of 62 resident physicians with a diagnosis of COVID-19 was selected from March 2020 to February 2023. Transthoracic echocardiograms were performed, and the findings were described.
Results: The main echocardiographic findings were: pericardial refractoriness (90.3%), pericardial effusion (6.5%), abnormal left ventricular mobility (1. 6%), abnormal diastolic function (8.1%), aortic regurgitation (6.5%), mitral regurgitation (19.4%), pulmonary regurgitation (35.5%), tricuspid regurgitation (80.6%), mean LVEF of 65% and PSAP of 23 mmHg.
Conclusions: The most relevant echocardiographic findings were refractory pericardium, pericardial effusion, left ventricular diastolic dysfunction, and valvular insufficiency, predominantly in men.
Descargas
Referencias
Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep [Internet]. 2020;19(100682):100682. Disponible en: http://dx.doi.org/10.1016/j.genrep.2020.100682.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19): A review: A review. JAMA. 2020;324(8):782–93. Disponible en: http://dx.doi.org/10.1001/jama.2020.12839.
Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. N Engl J Med [Internet]. 2020;383(25):2451–60. Disponible en: http://dx.doi.org/10.1056/NEJMcp2009575.
Peeling RW, Heymann DL, Teo Y-Y, Garcia PJ. Diagnostics for COVID-19: moving from pandemic response to control. Lancet [Internet]. 2022;399(10326):757–68. Disponible en: http://dx.doi.org/10.1016/S0140-6736(21)02346-1.
Elrobaa IH, New KJ. COVID-19: Pulmonary and extra pulmonary manifestations. Front Public Health. 2021;9:711616. Disponible en: http://dx.doi.org/10.3389/fpubh.2021.711616.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020;395(10229):1054–62. Disponible en: http://dx.doi.org/10.1016/S0140-6736(20)30566-3.
Kamath V, Nivea B, Markanday K, Jacob MJ, Mohan D. A cross-sectional study of pulmonary and extrapulmonary manifestations of COVID-19. APIK J Int Med [Internet]. 2021;9(4):250. Disponible en: http://dx.doi.org/10.4103/ajim.ajim_46_21.
Block JP, Boehmer TK, Forrest CB, Carton TW, Lee GM, Ajani UA, et al. Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination - PCORnet, United States, January 2021-January 2022. MMWR Morb Mortal Wkly Rep [Internet]. 2022;71(14):517–23. Disponible en: http://dx.doi.org/10.15585/mmwr.mm7114e1.
Mohammad KO, Lin A, Rodriguez JBC. Cardiac manifestations of post-acute COVID-19 infection. Curr Cardiol Rep [Internet]. 2022;24(12):1775–83. Disponible en: http://dx.doi.org/10.1007/s11886-022-01793-3.
Linschoten M, Peters S, van Smeden M, Jewbali LS, Schaap J, Siebelink H-M, et al. Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care [Internet]. 2020;9(8):817–23. Disponible en: http://dx.doi.org/10.1177/2048872620974605.
González-Calle D, Eiros R, Sánchez PL. Corazón y SARS-CoV-2. Med Clin (Barc). 2022;159(9):440–6. Disponible en: http://dx.doi.org/10.1016/j.medcli.2022.07.002.
Giacca M, Shah AM. The pathological maelstrom of COVID-19 and cardiovascular disease. Nat Cardiovasc Res [Internet]. 2022;1(3):200–10. Disponible en: http://dx.doi.org/10.1038/s44161-022-00029-5.
De A, Bansal M. Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019. Int J Cardiovasc Imaging [Internet]. 2023;39(5):887–94. Disponible en: http://dx.doi.org/10.1007/s10554-022-02787-6.
Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation [Internet]. 2020;141(23):1903–14. Disponible en: http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047349.
Garcia-Zamora S, Picco JM, Lepori AJ, Galello MI, Saad AK, Ayón M, et al. Abnormal echocardiographic findings after COVID-19 infection: a multicenter registry. Int J Cardiovasc Imaging [Internet]. 2023;39(1):77–85. Available from: https://doi.org/10.1007/s10554-022-02706-9.
Flores R, Pires O, Alves J, Pereira VH. An echocardiographic insight into post-COVID-19 symptoms. Cureus [Internet]. 2023;15(4):e38039. Disponible en: http://dx.doi.org/10.7759/cureus.38039.
Huang S, Vignon P, Mekontso-Dessap A, Tran S, Prat G, Chew M, et al. Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study). Intensive Care Med [Internet]. 2022;48(6):667–78. Disponible en: http://dx.doi.org/10.1007/s00134-022-06685-2.
Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging. 2020;21(9):949–58. Disponible en: http://dx.doi.org/10.1093/ehjci/jeaa178.
Armstrong W, Pellikka P, Ryan T, Crouse L, Zoghbi W, Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. J Am Soc Echocardiogr 1998;11:97-104.
World Medical Association Declaration of Helsinki) Ethical principles for medical research involving human subjects. JAMA 2000; 284:3043-5.
21. Castiello T, Georgiopoulos G, Finocchiaro G, Claudia M, Gianatti A, Delialis D, et al. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail Rev [Internet]. 2022;27(1):251–61. Disponible en: http://dx.doi.org/10.1007/s10741-021-10087-9
Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J [Internet]. 2022;43(11):1157–72. Disponible en: http://dx.doi.org/10.1093/eurheartj/ehac031.
Gao Y-D, Ding M, Dong X, Zhang J-J, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy [Internet]. 2021;76(2):428–55. Disponible en: http://dx.doi.org/10.1111/all.14657.
Ou M, Zhu J, Ji P, Li H, Zhong Z, Li B, et al. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect [Internet]. 2020;148(e175):e175. Disponible en: http://dx.doi.org/10.1017/S095026882000179X.
Capotosto L, Nguyen BL, Ciardi MR, Mastroianni C, Vitarelli A. Heart, COVID‐19, and echocardiography. Echocardiography [Internet]. 2020;37(9):1454–64. Disponible en: http://dx.doi.org/10.1111/echo.14834.
van Driest FY, Fejzovic V, Scholte AJHA, Jukema JW, Lamb HJ. COVID-19 associated perimyocarditis. Magn Reson Imaging [Internet]. 2021;84:132–4. Disponible en: http://dx.doi.org/10.1016/j.mri.2021.08.012.
Singh N, Hani ZB, AlRemeithi R. Abnormal echocardiographic findings after COVID-19 infection: a multicenter registry. Int J Cardiovasc Imaging [Internet]. 2023;39(2):285–6. Disponible en: http://dx.doi.org/10.1007/s10554-022-02732-7.
Barman HA, Atici A, Tekin EA, Baycan OF, Alici G, Meric BK, et al. Echocardiographic features of patients with COVID-19 infection: a cross-sectional study. Int J Cardiovasc Imaging [Internet]. 2021;37(3):825–34. Disponible en: http://dx.doi.org/10.1007/s10554-020-02051-9.
Corica B, Marra AM, Basili S, Cangemi R, Cittadini A, Proietti M, et al. Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis. Sci Rep [Internet]. 2021;11(1):17774. Disponible en: http://dx.doi.org/10.1038/s41598-021-96955-8.
Descargas
Publicado
Versiones
- 16-06-2025 (2)
- 29-10-2024 (1)
Número
Sección
Licencia
Los autores conservan sus derechos de autor y otorgan a la Revista Médica del IMSS el derecho de primera publicación. Los artículos se distribuyen bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional, que permite su difusión siempre que se reconozca al autor y la fuente original.
